Real-World Incidence of Bleeding Events in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib +/- Obinutuzumab and Requiring Direct Oral Anticoagulation.

15. Januar 2026

K Fenchel, E von der Heyde, M Zaiss, T Illmer, M Schulze, S Jäger, S Schroeder, Daniel Kummer, Patrick Marschner.

Blood (2025) 146 (Supplement 1): 2724. https://doi.org/10.1182/blood-2025-2724